http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cf6c8a93b84d0a2699bdb5fe1c6f603
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Dowsett |
| name | Mitch Dowsett |
| given-name | Mitch |
| organization-name | 1Academic Department of Biochemistry; Marsden Hospital and Breakthrough Breast Cancer Research Centre, London, United Kingdom Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital and The Institute of Cancer Research London UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research London UK From the Academic Department of Biochemistry and the Breast Unit, Royal Marsden Hospital, London; Mayday University Hospital, Croydon, Surrey; Edinburgh Breast Unit, Edinburgh; Royal Bournemouth Hospital, Bournemouth, Dorset; Royal Victoria Infirmary, Newcastle Upon Tyne, Tyne and Wear; and AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom Royal Marsden Hospital, London, United Kingdom; Institute of Cancer Research, London, United Kingdom From Intermountain Healthcare, University of Utah School of Medicine, Salt Lake City, UT; Washington University School of Medicine, St Louis, MO; American Society of Clinical Oncology, Alexandria, VA; University of Michigan Comprehensive Cancer Center, University of Michigan Health System; St Joseph Mercy Hospital; Gemini Group, Ann Arbor; Advanced Diagnostics Laboratory, Redford, MI; Presbyterian Hospital, Charlotte, NC; Indiana University, Bloomington, IN; St Jude Medical Center, Fullerton, CA;... 1Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom.; 3Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.; 5Breast Unit, Royal Marsden Hospital, London, United Kingdom. 1Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; 2Breast Unit, The Royal Marsden Hospital, London, United Kingdom. 1Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. Ralph Lauren Centre for Breast Cancer Research, Royal Marsden, London, England; Breast Cancer Now Research Centre, Institute of Cancer Research, London, England Institute of Cancer Research; London United Kingdom Division of Breast Cancer Research (M.R., E.J.F., M.D., A.A., A.J.S.), Sutton SM2 5NG and London SW3 6JB, United Kingdom;; Breakthrough Breast Cancer Research Centre (M.D., A.A.), Sutton SM2 5NG and London SW3 6JB, United Kingdom;; Division of Molecular Pathology (M.D., A.A.), The Institute of Cancer Research, University of London, Sutton SM2 5NG and London SW3 6JB, United Kingdom;; Biochemistry Department (MR., E.J.F., M.D.), Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, United Kingdom 2The Royal Marsden Hospital, London, United Kingdom; Mitch Dowsett, Elena Lopez-Knowles, and Kalvinder Sidhu, Royal Marsden Hospital; Ivana Sestak and Jack Cuzick, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Anita K. Dunbier, University of Otago, Dunedin, New Zealand; J. Wayne Cowens, Sean Ferree, and James Storhoff, NanoString Technologies, Seattle, WA; and Carl Schaper, Myraqa, Redwood Shores, CA. Royal Marsden Hospital, London, United Kingdom Jack Cuzick, Silvia Pineda, and Christopher Wale, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Mitch Dowsett, Janine Salter, Emma Quinn, and Lila Zabaglo, Royal Marsden Hospital, London; Elizabeth Mallon, Western Infirmary, North Glasgow University Hospital, Glasgow; Andrew R. Green and Ian O. Ellis, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals National Health Services Trust, City Hospital,... The Institute of Cancer Research London UK 1Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom.; 4Royal Marsden Hospital, London, United Kingdom. Department of Biochemistry (E.F., M.D.), Royal Marsden Hospital, London SW3 6JJ, United Kingdom 7Department of Medicine, Royal Marsden Hospital, London, United Kingdom; Authors' Affiliations: 1Academic Department of Biochemistry, Royal Marsden Hospital and 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom; Authors' Affiliations: 1Academic Department of Biochemistry, Royal Marsden Hospital and 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom 1Royal Marsden Hospital, London, United Kingdom.; 2Breast Cancer Now Toby Robins Center for Breast Cancer Research, Institute of Cancer Research, London, United Kingdom. 3The Breast Cancer Now Research Centre, Institute of Cancer, London, United Kingdom.; 4Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom. Mitch Dowsett and Andrew Dodson, Royal Marsden Hospital; Mitch Dowsett, Institute of Cancer Research; Ivana Sestak and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom; Meredith M. Regan, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA; Giuseppe Viale, University of Milan; Guiseppe Viale and Marco Colleoni, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital St Gallen, St Gallen, and International... Authors' Affiliations: 1Academic Biochemistry, Royal Marsden Foundation Trust;; 2Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; From the Departments of Medicine and Academic Department of Biochemistry, Royal Marsden Hospital; Department of Medical Oncology, Guy’s Kings & St Thomas’ Cancer Centre, Guy’s Hospital, London; Department of Haematology & Oncology, Royal Bournemouth General Hospital, Bournemouth; St Luke’s Cancer Centre, Royal Surrey County Hospital, Guilford; CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton; Johnson & Johnson Pharmaceutical Research & Development, Saunderton, United Kingdom; and... Royal Marsden Hospital NHS Foundation Trust; Cancer Research Centre; The Institute of Cancer Research, University of London, London, United Kingdom Department of Biochemistry, Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Fulham Road, London, UK. mitch.dowsett@icr.ac.uk The Royal Marsden NHS Foundation Trust, Sutton, UK Royal Marsden Hospital; and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom 3Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; 4Academic Department of Biochemistry, The Royal Marsden Hospital, London, United Kingdom. 6The Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom. 3Royal Marsden Hospital, London, United Kingdom.; 5Breast Cancer Now Research Centre, The Institute of Cancer Research, Sutton, London, United Kingdom. 8Department of Medicine, Royal Marsden Hospital, London, United Kingdom Academic Department of Biochemistry, 4th Floor, Wallace Wing, The Royal Marsden Hospital, Fulham Road, London SW3 6 JJ, UK. mitch.dowsett@icr.ac.uk From the Royal Marsden National Health Service Foundation Trust; The Institute of Cancer Research, Sutton, Surrey, United Kingdom; and Cougar Biotechnology, Los Angeles, CA. 4Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom; and 1Academic Department of Biochemistry and 3Institute of Cancer Research, London, United Kingdom; and Scooter Willis, Yuliang Sun, Brandon Young, Xiaoqian Lin, Stephanie Theel, Jennifer Carlson, Casey Williams, Mark Abramovitz, and Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Varvara Polydoropoulou, Zoi Tsourti, Dimitris Karlis, and Urania Dafni, Frontier Science Foundation-Hellas; Urania Dafni, University of Athens, Athens, Greece; Bradley Long, Scripps Florida, Jupiter, FL; Balazs Győrffy, MTA-TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary; and Mitch Dowsett, Royal... From the Royal Marsden Hospital Institute of Cancer Research, London, United Kingdom; Section of Oncology, Department of Medicine, Haukeland University Hospital, Bergen, Norway; University of Virginia Health Sciences Center, Charlottesville, VA; and the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 1The Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London, United Kingdom.; 2Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom. Authors' Affiliations: 1Section of Oncology, Institute of Medicine, University of Bergen, and 2Department of Oncology, Haukeland University Hospital, Bergen, Norway; 3Department of Academic Biochemistry, Royal Marsden Hospital, London, United Kingdom Ralph Lauren Centre for Breast Cancer Research The Royal Marsden Hospital London UK; The Institute of Cancer Research London UK 2Academic Department of Biochemistry, Royal Marsden Hospital; The Institute of Cancer Research, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom From the Siteman Comprehensive Cancer Center, Washington University School of Medicine, St Louis, MO; Duke University Medical Center, Durham, NC; Edinburgh Breast Unit, Edinburgh University, Edinburgh, Scotland; Royal Marsden Hospital, London, United Kingdom; and Novartis Pharma AG, Basel, Switzerland. Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John Wayne Cowens, Sean Ferree, NanoString Technologies, Seattle, WA; and Carl Shaper, MyRAQA, Redwood Shores, CA. Authors' Affiliations: 1Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 2Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom; and 3Department of Biochemistry, University of Otago, Dunedin, New Zealand; Authors' Affiliations: 1Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 2Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom; and 3Department of Biochemistry, University of Otago, Dunedin, New Zealand Authors' Affiliations: 1Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 2Department of Academic Biochemistry, The Royal Marsden Hospital; and 3London Research Institute, Cancer Research UK, London, United Kingdom; Authors' Affiliations: 1Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 2Department of Academic Biochemistry, The Royal Marsden Hospital; and 3London Research Institute, Cancer Research UK, London, United Kingdom From the Academic Department of Biochemistry, Royal Marsden Hospital; Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Queen Mary University of London; Clinical Trials Group, Royal Free and University College London Medical School; Department of Cancer Medicine, Charing Cross Hospital, London; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey; Clinical Trials Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom;... Section of Oncology, Institute of Medicine, University of Bergen, and Academic Department of Biochemistry, Royal Marsden Hospital National Health Service Trust, London, United Kingdom Gong Tang, Joseph P. Constantino, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers; Gong Tang and Joseph P. Constantino, University of Pittsburgh; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Mitch Dowsett, the Royal Marsden Hospital, London, United Kingdom; John F. Forbes, University of Newcastle, Calvary Mater... The Royal Marsden National Health Service Foundation Trust, London, United Kingdom; The Institute of Cancer Research, London, United Kingdom The Royal Marsden Hospital and Breakthrough Breast Cancer Research Centre, London, United Kingdom Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust, Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK 2Institute of Cancer Research, London, United Kingdom and Authors' Affiliations: 1Academic Biochemistry and 2Medicine, Royal Marsden Hospital, London, United Kingdom; 3Department of Oncology, Haukeland University Hospital; 4Department of Molecular Biology and 5Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway; 6Institute of Medicine, University of Oslo, Faculty Division at Akershus University Hospital, Lørenskog, Norway; and 7Cancer Research UK Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, Surrey, United Kingdom From the Department of Public Health and Primary Care (K.-T.K., R.L., A.W., N.D.), Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, UK; Academic Department of Biochemistry (M.D., E.F.), Royal Marsden Hospital, London, UK; and MRC Dunn Human Nutrition Unit (S.B.) and MRC Epidemiology Unit (N.W.), Cambridge, UK. William Beaumont Hospital, Royal Oak; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom From the Royal Marsden Hospital, London, United Kingdom; Sunnybrook and Women's College, Health Science Center, Toronto, Canada; Netherlands Cancer Institute, Amsterdam, the Netherlands; Centre Jean Perrin, Clermont-Ferrand, France; Klinikum Kassel, Kassel, Germany; Tokai University School of Medicine, Kanagawa, Japan; and Westmead Hospital, Westmead, New South Wales, Australia. 3The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom.; 6Academic Department of Biochemistry, Royal Marsden NHS Foundation Trust, London, United Kingdom. The Institute of Cancer Research , London, UK 1Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; 3Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom. Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand. Mitch Dowsett, PhD, Ralph Lauren Centre for Breast Cancer Research, Royal Marden Hospital, London, UK and Ivana Sestak, PhD and Jack Cuzick, PhD, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK 2Academic Department of Biochemistry, and; 4Biochemistry Department, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom Charlotte Fribbens, Ben O’Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France;... 4Institute of Cancer Research, London, United Kingdom From the Department of Oncology, Haukeland University Hospital, Bergen, Norway; and the Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. Authors' Affiliations: Departments of 1Cancer Biology, 2Medicine, 3Biostatistics, and 4Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee; 5Breakthrough Breast Cancer Centre, Institute of Cancer Research; 6Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom; Departments of 7Breast Medical Oncology and 8Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 9Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom; Authors' Affiliations: Departments of 1Cancer Biology, 2Medicine, 3Biostatistics, and 4Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee; 5Breakthrough Breast Cancer Centre, Institute of Cancer Research; 6Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom; Departments of 7Breast Medical Oncology and 8Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 9Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom Elizabeth J. Folkerd and Mitch Dowsett, Royal Marsden Hospital, London; J. Michael Dixon and Lorna Renshaw, Western General Hospital, Edinburgh; and Roger P. A'Hern, Institute for Cancer Research, Sutton, United Kingdom. 4Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom The Breakthrough Breast Cancer Research Center The Institute of Cancer Research London United Kingdom; Academic Department of Biochemistry The Royal Marsden Foundation Trust London United Kingdom 6Ralph Lauren Breast Cancer Research Centre, Royal Marsden Hospital, London, United Kingdom. Ralph Lauren Centre for Breast Cancer Research, London, United Kingdom Ralph Lauren Centre for Breast Cancer Research, Royal Marsden, London, UK. Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health... From the Academic Department of Biochemistry, Royal Marsden Hospital; Departments of Epidemiology and Mathematics & Statistics, Cancer Research UK, Wolfson Institute of Preventive Medicine; Clinical Trials Group, Department of Surgery, University College London, London; Department of Pathology, The Western Infirmary, Glasgow; Department of Surgery, The Royal Bolton Hospital, Bolton; Department of Histopathology, Nottingham University, Nottingham City Hospital, Nottingham; Bradford Teaching Hospitals NHS... 2Breakthrough Breast Cancer Centre and; 3Department of Academic Biochemistry, Institute of Cancer Research; From the Institute for Cancer Research; and The Royal Marsden Hospital and Breakthrough Breast Cancer Research Centre, London, United Kingdom. 1Breakthrough Breast Cancer Centre, Institute of Cancer Research; and; 3Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom Authors' Affiliations: 1Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research and 2Academic Department of Biochemistry, The Royal Marsden Hospital, London, United Kingdom; Authors' Affiliations: 1Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research and 2Academic Department of Biochemistry, The Royal Marsden Hospital, London, United Kingdom Authors' Affiliations: Departments of 1Cancer Biology, 2Medicine, 3Biostatistics, 4Radiology and Radiological Sciences, and 5Pathology; 6Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; 7Institute of Imaging Sciences, Vanderbilt University, Nashville, Tennessee; 8Breakthrough Breast Cancer Centre, Institute of Cancer Research, and 9Academic Department of Biochemistry, Royal Marsden Hospital, London, UK; 10Novartis Institute for Biomedical Research, Oncology Disease Area, Basel, Switzerland; Departments of 11Breast Medical Oncology and 12Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 13Breast Research Group, University of Edinburgh, Edinburgh, UK; Authors' Affiliations: Departments of 1Cancer Biology, 2Medicine, 3Biostatistics, 4Radiology and Radiological Sciences, and 5Pathology; 6Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; 7Institute of Imaging Sciences, Vanderbilt University, Nashville, Tennessee; 8Breakthrough Breast Cancer Centre, Institute of Cancer Research, and 9Academic Department of Biochemistry, Royal Marsden Hospital, London, UK; 10Novartis Institute for Biomedical Research, Oncology Disease Area, Basel, Switzerland; Departments of 11Breast Medical Oncology and 12Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 13Breast Research Group, University of Edinburgh, Edinburgh, UK Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK Academic Department of Biochemistry (E.F., D.D., M.D.), Royal Marsden Hospital, London SW3 6JJ, United Kingdom Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK 1Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Trust, London, United Kingdom. Authors' Affiliations: 1Royal Marsden Hospital; 2Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 3Cancer Research UK Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, London; 4Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom; and 5Department of Biochemistry, University of Otago, Dunedin, New Zealand; Authors' Affiliations: 1Royal Marsden Hospital; 2Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 3Cancer Research UK Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, London; 4Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom; and 5Department of Biochemistry, University of Otago, Dunedin, New Zealand From the Endocrine Cancer Group, Edinburgh Cancer Research Centre, Western General Hospital; Department of Oncology, Western General Hospital, Lothian University Hospitals Trust, Edinburgh; Molecular Medical Sciences, Department of Histopathology, University of Nottingham, Nottingham City Hospital, Nottingham; Department of Pathology, Western Infirmary, Glasgow; Department of Medicine, Breast Unit, Royal Marsden Hospital, London; Section of Clinical Trials—The Institute of Cancer Research Section of... Alistair Ring, Brighton and Sussex Medical School, Sussex Cancer Centre, Brighton; Ivana Sestak and Jack Cuzick, Cancer Research UK Centre for Epidemiology, Mathematics, and Statistics, Wolfson Institute of Preventive Medicine; Michael Baum, Cancer Research UK/University College London Cancer Trials Centre, University College London; Mitch Dowsett, Royal Marsden Hospital, London; Anthony Howell, The Christie National Health Service Trust, University of Manchester, Manchester, United Kingdom; Aman Buzdar,... Royal Marsden Hospital, London, UK 1Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Trust, London, United Kingdom.; 2The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom. 3Department of Academic Biochemistry, Royal Marsden Hospital, London, United Kingdom; From the Academic Department of Biochemistry and Breast Unit, Royal Marsden Hospital, London, UK From the Royal Marsden Hospital; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; and Cancer Research United Kingdom Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, London, United Kingdom; Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC; and Washington University and Siteman Cancer Center, St Louis, MO. From the Royal Marsden Hospital; Wolfson Institute for Preventive Medicine, Queen Mary University of London; University College London, London; Royal Infirmary Glasgow; Christie Hospital, Manchester, United Kingdom; Newcastle Mater Hospital, Newcastle, New South Wales, Australia; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Genomic Health, Redwood City, CA. Authors' Affiliations: 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 2Academic Department of Biochemistry, and 3Breast Unit, Royal Marsden Hospital, London, United Kingdom; Authors' Affiliations: 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 2Academic Department of Biochemistry, and 3Breast Unit, Royal Marsden Hospital, London, United Kingdom; Authors' Affiliations: 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 2Academic Department of Biochemistry, and 3Breast Unit, Royal Marsden Hospital, London, United Kingdom 4Royal Marsden Hospital, London, United Kingdom From the Department of Academic Biochemistry, Royal Marsden Hospital, London, United Kingdom; Frontier Science (Scotland) Ltd, Kincraig, Kingussie, Scotland; National Cancer Institute, National Institutes of Health, Bethesda, MD; Departments of Medical Oncology and Medicine, Institut Jules Bordet, Université Libre de Bruxelles; Breast European Adjuvant Studies Team, Brussels, Belgium; Department of Public Health, School of Nursing, University of Athens, Athens, Greece; TARGOS Molecular Pathology GmbH,... From the Edinburgh Breast Unit and Department of Oncology, Western General Hospital, Edinburgh; Academic Department of Biochemistry, Royal Marsden Hospital, London; and the Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom From the Royal Marsden Hospital and Institute of Cancer Research; Royal Marsden Hospital, London; Royal Bournemouth Hospital, Bournemouth; AstraZeneca, Macclesfield, United Kingdom; Hospital Arnau I Vilanova, Lleida; and Hospital Lozano Blesa, Zaragoza, Spain. Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK; Ralph Lauren Centre for Breast Cancer Research Department of Biochemistry, the Royal Marsden Hospital, London, England Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital and The Institute of Cancer Research, London, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK Academic Department of Biochemistry, Royal Marsden Hospital, London SW3 6JJ, United Kingdom. mitch@icr.ac.uk 3Institute of Cancer Research and Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. Academic Department of Biochemistry, The Royal Marsden NHS Trust, London, UK. Royal Marsden Hospital, London, England From the Royal Marsden Hospital; Cancer Research UK; University College London, London; Christie Hospital, Manchester, UK. Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research London UK; Academic Department of Biochemistry, Royal Marsden Hospital Fulham Road London 1The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. Mitch Dowsett, PhD, Royal Marsden Hospital, London, United Kingdom; and Nicholas Turner, MD, PhD, Institute of Cancer Research, London, United Kingdom From the Royal Marsden NHS Foundation Trust; and The Institute of Cancer Research, Sutton, Surrey, United Kingdom; and Cougar Biotechnology, Los Angeles, CA 5Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom From the Breast Center and Departments of Pathology and Medicine, Baylor College of Medicine, Houston, TX; and Academic Department of Biochemistry and Breast Unit, Royal Marsden Hospital, London, United Kingdom From Cancer Research UK; Queen Mary University of London, London; Royal Marsden Hospital; Christie Hospital National Health Service Trust; Cancer Research UK, Manchester, United Kingdom; Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Dresden, Germany; and University of Newcastle, Newcastle, Australia. Authors' Affiliations: 1Royal Marsden Hospital and 2Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom; and 3Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark; Authors' Affiliations: 1Royal Marsden Hospital and 2Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom; and 3Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark 17Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom. 1The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom.; 6Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. The Breast Cancer Now Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.; Breast Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. 7Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom Ian Smith and Mitch Dowsett, Royal Marsden Hospital; Institute of Cancer Research, London, United Kingdom; Denise Yardley and Howard A. Burris, Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN; Richard De Boer, Royal Melbourne and Western Hospitals, Melbourne, Australia; Dino Amadori, Istituto Scientifico Romagnolo per lo Studio e la Cura del Tumori Istituto di Ricovero eCura a Carattere Scientifico, Meldola; Lisa Comarella, CROS NT, Verona, Italy; Kristi McIntyre and Joyce... |
Incoming Links
Total number of triples: 472.